|
Volumn 93, Issue 5, 2000, Pages 1345-1349
|
Clinical uses of α2-adrenergic agonists
|
Author keywords
Anesthesia; Anxiolysis; Clonidine; Dexmedetomidine; Pain; Sedation; Sympat holysis; 2 Adrenergic receptor
|
Indexed keywords
ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT;
ATIPAMEZOLE;
CLONIDINE;
DEXMEDETOMIDINE;
DIZOCILPINE;
FENTANYL;
GUANINE NUCLEOTIDE BINDING PROTEIN;
ISOFLURANE;
LOCAL ANESTHETIC AGENT;
MIVAZEROL;
NITROUS OXIDE;
OPIATE AGONIST;
PROPOFOL;
SUFENTANIL;
VECURONIUM;
ALPHA 2 ADRENERGIC RECEPTOR;
ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT;
ANALGESIA;
ATTENTION DEFICIT DISORDER;
BRADYCARDIA;
CARDIOVASCULAR EFFECT;
CLINICAL TRIAL;
DOSE RESPONSE;
DRUG ANTAGONISM;
DRUG EFFECT;
DRUG HALF LIFE;
DRUG MECHANISM;
DRUG RECEPTOR BINDING;
HEART MUSCLE ISCHEMIA;
HUMAN;
HYPERTENSION;
HYPNOSIS;
HYPOTENSION;
IN VITRO STUDY;
IN VIVO STUDY;
MEMORY;
MOUSE;
NONHUMAN;
PAIN;
PRIORITY JOURNAL;
REVIEW;
SCHIZOPHRENIA;
SEDATION;
SHIVERING;
TRANQUILIZING ACTIVITY;
ANIMAL;
CONTROLLED CLINICAL TRIAL;
DRUG POTENTIATION;
RANDOMIZED CONTROLLED TRIAL;
ADRENERGIC ALPHA-AGONISTS;
ANIMALS;
HUMANS;
RANDOMIZED CONTROLLED TRIALS;
RECEPTORS, ADRENERGIC, ALPHA-2;
|
EID: 0033623230
PISSN: 00033022
EISSN: None
Source Type: Journal
DOI: 10.1097/00000542-200011000-00030 Document Type: Review |
Times cited : (672)
|
References (20)
|